BATS BZX Real-Time Price
As of 2:44pm ET
| +0.30 / +5.36%|
The 4 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 26.00, with a high estimate of 33.00 and a low estimate of 15.00. The median estimate represents a +340.68% increase from the last price of 5.90.
The current consensus among 3 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.